Abstract B02: Liquid biopsy for screening of driver mutations in EGFR gene: Personalized medicine for use tyrosine kinase inhibitors in non-small cell lung cancer patients

2018 ◽  
Author(s):  
Priscila D. R. Cirillo ◽  
Natália P. Lopes ◽  
Carolina Bustamante ◽  
Agatha A. Morais ◽  
Natália L. Viana ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Personalized Medicine ◽  
Cancer Patients ◽  
Liquid Biopsy ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Driver Mutations ◽  
Small Cell Lung ◽  
Egfr Gene ◽  
Lung Cancer Patients

scholarly journals Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors

2008 ◽  
Vol 19 (9) ◽  
pp. 1605-1612 ◽  
Author(s):  
P.A. Zucali ◽  
M.G. Ruiz ◽  
E. Giovannetti ◽  
A. Destro ◽  
M. Varella-Garcia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Kinase Inhibitors ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Egfr Tyrosine Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document